CDC73 and ossifying fibroma: The data from the above-described studies provided, both in an animal model and in humans, concordant evidence that the loss of the nuclear expression of parafibromin in bone-forming cells may have an important, direct, role in the pathogenesis of ossifying fibromas, confirming these skeletal neoplasms as a primary clinical manifestation and direct consequence of the genetic defect in the CDC73 gene.